Fresenius Kabi Awaits EMA Inspection For Pegfilgrastim Biosimilar

Facing Greater Challenge For FDA Approval

 
• By Dean Rudge
  
Start Launch
Fresenius Kabi aims to launch pegfilgrastim in the EU and US next year • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products